Allied Research International (ARI), Canada's leading contract research organization (CRO), announced today that it has acquired key assets of South Florida Bioavailability Clinic International's (SFBC) Miami, Florida operations.
TORONTO – August 16, 2006 – Allied Research International (ARI), Canada's leading contract research organization (CRO), announced today that it has acquired key assets of South Florida Bioavailability Clinic International's (SFBC) Miami, Florida operations. The acquired assets include a fully-functional clinical laboratory and equipment, and a 46-station cardiac monitoring suite.
"These assets will be re-located to ARI's new state-of-the-art, 150-bed Phase 1 clinic in Miami that opened this spring. ARI will also employ selected leading staff from SFBC's Miami operations," said Dr. Piyush Patel MD, CEO and Founder of ARI.
ARI now has significantly expanded capacity to perform complex Phase 1 and special population studies in the Miami area, There is a large need for these types of studies and for which few other CROs specialize.
The expanded facilities in Miami add to ARI's 80-bed Phase 1 unit in Toronto, Canada, bringing its total capacity to over 230 Phase I beds.
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.
Improving Engagement While Maintaining Data Integrity & Validity
March 19th 2024In recognition of Women's Health Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and uMotif's Chief Product Officer, Julia Lakeland, discuss new technologies improving patient engagement and reducing the emotional and logistical burdens of participation, ethical considerations that should be addressed when implementing those technologies, while ensuring patient privacy, and much more.